Researchers continue to uncover new applications for GLP-1 agonist drugs, which are traditionally known for their role in managing diabetes and obesity.
Recent findings suggest that these medications may also be effective in addressing substance abuse issues, highlighting the versatility of these treatments.
This trend of drug repurposing is not new; it has previously played a critical role in finding effective therapies during health crises, such as the COVID-19 pandemic.